Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer's Disease

• Main Authors: Nikita Navolokin (Author), Viktoria Adushkina (Author), Daria Zlatogorskaya (Author), Valeria Telnova (Author), Arina Evsiukova (Author), Elena Vodovozova (Author), Anna Eroshova (Author), Elina Dosadina (Author), Sergey Diduk (Author), Oxana Semyachkina-Glushkovskaya (Author)
• Format: Book
• Published: MDPI AG, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The COVID-19 pandemic, caused by infection with the SARS-CoV-2 virus, is associated with cognitive impairment and Alzheimer's disease (AD) progression. Once it enters the brain, the SARS-CoV-2 virus stimulates accumulation of amyloids in the brain that are highly toxic to neural cells. These am...